Stryker's shares declined 6.5% following earnings as the market reacted negatively to the significant impact of a late-quarter cyber incident, which disrupted revenue recognition and led to meaningful margin pressure despite stable underlying demand.

• Organic sales growth moderated to 2.4%, reflecting constrained revenue due to cyber-related operational disruptions late in the quarter.
• Adjusted EPS declined 8.5% year-over-year to $2.60, weighed down by lost manufacturing absorption, tariffs, and higher interest expense.
• The cyber incident caused shipment delays and revenue timing distortions, prompting management to withhold normal segment-level details this quarter.
• Robust procedural demand and elevated capital order book signals underlying market health despite first-quarter headwinds.
• The company reaffirmed full-year guidance, anticipating normalization as recovery efforts conclude.